Project description
Improving use of photonics in healthcare
Photonics is the science and technology of light. Combining optics and electronics, it deals with generating, guiding, manipulating, amplifying and detecting light. The widespread use of photonics technologies in medical applications (from diagnostic devices to instruments for treatment) has given rise to challenges for both end-user companies and manufacturers. The EU-funded MedPhab project will address these challenges. It will serve as Europe’s first pilot line dedicated to manufacturing, testing, validating and upscaling new photonics technologies for medical diagnostics enabling accelerated product launch with reduced R&D costs. The MedPhab operation process and technology readiness will be validated by upscaling and demonstrating the performance of five innovative medical diagnostics products. A demo case open calls programme will also facilitate the early adoption of the technologies by external users.
Objective
Photonics technologies have become a key enabler in the realization of modern medical devices with applications ranging from diagnostics to surgical tools and therapeutics. Characteristic nature of both photonics and application fields is high diversity. Consequently, the more widespread use of photonics technologies in scattered ecosystems presents major challenges for both end-user companies and manufacturers. In conjunction with highly regulated validation and production, the timespan from the concept phase to product launch takes years. Addressing these challenges, MedPhab will serve as Europes first Pilot Line dedicated to manufacturing, testing, validation and up-scaling of new photonics technologies for medical diagnostics enabling accelerated product launch with reduced R&D costs. MedPhab will bring the high-quality infrastructure and extensive know-how within easy reach of the SMEs and other European Industry. Globally unique feature of MedPhab is its operation in medical domain setting requirements to meet regulations. The competitive differentiation is the seamless operation between ISO13485 certified companies and RTOs when single-entry point can serve SMEs operating at different TRLs. Professional customer interface will be operated by staff with extensive experience in the field medical devices. The technology readiness and MedPhab operation process will be validated by:
1) Use Case Validation program, upscaling and demonstrating performance of 5 innovative medical diagnostics products;
2) Demo Case Open Calls program enabling early adoption of the technologies by external user, demonstrating the pilot line services and validating the open access business model.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Programme(s)
Funding Scheme
IA - Innovation actionCoordinator
02150 Espoo
Finland
See on map
Participants (21)
T12 YN60 Cork
See on map
8010 Graz
See on map
3001 Leuven
See on map
2000 Neuchatel
See on map
5656 AG Eindhoven
See on map
1230 Wien
See on map
90620 Oulu
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
91767 Palaiseau Cedex
See on map
T45HX08 Carrigtwohill
See on map
90440 Kempele
See on map
Participation ended
IP31 HF29 Cork
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participation ended
9052 Zwijnaarde
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4261 Rainbach Im Muhlkreis
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1120 Wien
See on map
1066 CX Amsterdam
See on map
75116 PARIS 16
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participation ended
162 00 Praha
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
162 00 Prague
See on map
9050 Gent
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
A98 R208 Dublin
See on map
00290 Helsinki
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.